We are live on ! Find out more
RJFSA

Raymond James Financial Services Advisors Portfolio holdings

AUM $75.1B
1-Year Est. Return 31.89%
This Fund
S&P 500
This Quarter Est. Return
+5.67%
1 Year Est. Return
+31.89%
3 Year Est. Return
+38.17%
5 Year Est. Return
+106.56%
10 Year Est. Return
+236.84%
AUM
$16B
AUM Growth
+$364M
Cap. Flow
-$374M
Cap. Flow %
-2.34%
Top 10 Hldgs %
13.67%
Holding
2,790
New
234
Increased
1,278
Reduced
908
Closed
258

Sector Composition

Rank Sector Weight
1 Technology 8.43%
2 Financials 6.74%
3 Healthcare 6.54%
4 Consumer Staples 5.82%
5 Industrials 5.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IMGN
2401
DELISTED
Immunogen Inc
IMGN
$77K ﹤0.01%
12,084
-10,564
-47% -$65.2K
KERX
2402
DELISTED
Keryx Biopharmaceuticals Inc
KERX
$77K ﹤0.01%
16,585
-940
-5% -$5.18K
AVTX icon
2403
Avalo Therapeutics
AVTX
$983M
$74K ﹤0.01%
+8
New +$34.5K
CELH icon
2404
Celsius Holdings
CELH
$7.03B
$74K ﹤0.01%
42,495
DWSN icon
2405
Dawson Geophysical
DWSN
$135M
$74K ﹤0.01%
15,719
-5,895
-27% -$27.5K
AXAS
2406
DELISTED
Abraxas Petroleum Corp
AXAS
$74K ﹤0.01%
1,500
-1,855
-55% -$77K
RMTI icon
2407
Rockwell Medical
RMTI
$28.2M
$73K ﹤0.01%
114
IAF
2408
abrdn Australia Equity Fund
IAF
$127M
$70K ﹤0.01%
3,653
-733
-17% -$13.8K
PFX icon
2409
PhenixFIN
PFX
$90M
$70K ﹤0.01%
+670
New +$76.4K
TEN
2410
Tsakos Energy Navigation Ltd
TEN
$1.18B
$70K ﹤0.01%
3,580
-501
-12% -$10.8K
FGP
2411
DELISTED
Ferrellgas Partners, L.P.
FGP
$69K ﹤0.01%
16,194
+4,628
+40% +$21.3K
NG icon
2412
NovaGold Resources
NG
$3.33B
$68K ﹤0.01%
17,210
-6,295
-27% -$25K
PETX
2413
DELISTED
Aratana Therapeutics, Inc.
PETX
$68K ﹤0.01%
13,008
+470
+4% +$2.88K
BTG icon
2414
B2Gold
BTG
$6.64B
$67K ﹤0.01%
21,600
FSM icon
2415
Fortuna Silver Mines
FSM
$3.07B
$67K ﹤0.01%
+12,833
New +$57.8K
NCZ
2416
Virtus Convertible & Income Fund II
NCZ
$301M
$67K ﹤0.01%
+2,705
New +$67.1K
WIN
2417
DELISTED
Windstream Holdings Inc
WIN
$67K ﹤0.01%
+7,248
New +$74.2K
TRQ
2418
DELISTED
Turquoise Hill Resources Ltd
TRQ
$66K ﹤0.01%
1,920
+150
+8% +$4.72K
CASI
2419
DELISTED
CASI Pharmaceuticals
CASI
$65K ﹤0.01%
2,009
-3,505
-64% -$95.2K
KWY
2420
Kingsway Corp
KWY
$293M
$63K ﹤0.01%
12,400
GTE icon
2421
Gran Tierra Energy
GTE
$317M
$62K ﹤0.01%
2,302
F icon
2422
CALL
Ford
F
$55.7B
$61K ﹤0.01%
63,800
-13,100
-17% -$161K
UAN icon
2423
CVR Partners
UAN
$1.34B
$61K ﹤0.01%
1,858
+844
+83% +$28K
LYG icon
2424
Lloyds Banking Group
LYG
$91.3B
$60K ﹤0.01%
+16,025
New +$57.8K
VIVS
2425
VivoSim Labs
VIVS
$1.64M
$55K ﹤0.01%
171
+57
+50% +$21.2K

Similar funds

Raymond James Financial Services Advisors's Q4 2017 Portfolio in Review

As of Q4 2017, Raymond James Financial Services Advisors held 2,790 positions worth $16B, up 2.3% from $15.6B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Raymond James Financial Services Advisors's Q4 2017 filing shows 234 new, 1,278 increased, 908 reduced and 258 closed positions. Its largest new stake was JPMorgan Diversified Return US Mid Cap Equity ETF: 221,656 shares worth $14.1M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $279M.

By sector, the portfolio is most concentrated in Technology at 8.4% of assets, up from 7.7% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James Financial Services Advisors's largest Q4 2017 buy was JPMorgan Diversified Return US Mid Cap Equity ETF: 221,656 shares worth $14.1M.
  • Raymond James Financial Services Advisors added most to Vanguard S&P 500 ETF in Q4 2017, an estimated $43.1M increase.
  • Raymond James Financial Services Advisors's biggest Q4 2017 reduction was PepsiCo, cutting an estimated $34.9M.
  • Raymond James Financial Services Advisors fully exited State Street SPDR S&P 500 ETF Trust in Q4 2017, selling an estimated $279M.
  • Raymond James Financial Services Advisors's ten largest holdings make up 14% of its $16B portfolio in Q4 2017.
  • Raymond James Financial Services Advisors opened 234 new positions and closed 258 in Q4 2017.
  • Raymond James Financial Services Advisors's portfolio value rose 2.3% quarter-over-quarter to $16B.

Based on Raymond James Financial Services Advisors's 13F filing for Q4 2017, filed 9 Feb 2018.